Outcomes for Lumbar Decompressions With Use of Liposomal Bupivicaine

• Status: Not yet recruiting
• Trial end date: 2022-01-01
• Target enrollment: 0
• Participant gender: All

Summary

Evaluate the benefit of using liposomal bupivicaine in lumbar laminectomies in terms of length of stay, IV narcotic use, 30-day narcotic use, visual analog score (VAS) and 30-day readmissions

• Phase: Phase 2
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: University of Colorado, Denver
• Treatments: Anesthetics; Anesthetics, Local; Bupivacaine

Criteria

Inclusion Criteria:

1. Male or Female

2. Adult (≥18 yo)

3. Lumbar stenosis

Exclusion Criteria:

1. Co-morbidities precluding surgery

2. ≤18 yo

3. Pregnant

4. Breastfeeding

5. Need for instrumented fusion

6. Prisoners

7. Intra-operative CSF leak (identified by gush of CSF)

8. Daily pre-operative opioid use of > 25 morphine Eq/day

9. Previous lumbar surgery at indicated level